English
Segment disclosures
Company overviewOCUGEN, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
2 dimension combinations 18 retained observations 11 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Reportable Segment · Collaborative Arrangement
Statement Business Segments · Type Of Arrangement
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ocgn:ReportableSegmentMember;us-gaap:TypeOfArrangementAxis=us-gaap:CollaborativeArrangementMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 1481000 | USD | 20250509 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 4055000 | USD | 20250305 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1014000 | USD | 20250509 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6036000 | USD | 20250305 | Open filing evidence |
Collaborative Arrangement · Reportable Segment
Type Of Arrangement · Statement Business Segments
Source dimensions
us-gaap:TypeOfArrangementAxis=us-gaap:CollaborativeArrangementMember;us-gaap:StatementBusinessSegmentsAxis=ocgn:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1488000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 3022000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1533000 | USD | 20260508 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 4413000 | USD | 20260304 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1752000 | USD | 20251105 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4606000 | USD | 20251105 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1373000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2854000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1481000 | USD | 20260508 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 4055000 | USD | 20260304 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1136000 | USD | 20251105 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3291000 | USD | 20251105 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1141000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2155000 | USD | 20250804 | Open filing evidence |